Apnea in the paediatric population is associated with increased morbidity and mortality in a large number of developed as well as developing countries. It is even more prominent in preterm newborn infants and is commonly referred to as apnea of prematurity. Its current diagnosis and therapy involve the use of traditional technologies which often result in discomfort to the infants due to the use of invasive devices attached to their sensitive skin, especially in overnight clinical sleep analysis (for over 12- or 24-hour period). Emerging trends for the point-of-care diagnosis of this sleep disorder are focused on the design of integrated devices for less complex and non-invasive monitoring. This paper presents a review of the state-of-art of clinical technologies and methodologies for sleep apnea detection and their pros and cons, with particular focus on their working principles and relevance to paediatrics. Moreover, an in-depth discussion on emerging future technologies envisioned to be integral parts of the daily home-based applications is included in the paper.

Recently, the incidence of, and interest in, respiratory diseases has been amplified by severe acute respiratory syndrome coronavirus (SARS-CoV-2) and other respiratory diseases with a high prevalence. Most of these diseases require mechanical ventilation for homecare and clinical therapy. Herein, we propose a portable and non-invasive mechanical fan (NIV) for home and clinical applications. The NIV’s core is a turbine for airflow generation, which can provide and monitor a positive two-level pressure of up to approximately 500 lpm at 50 cmH₂O according to the inspiration/expiration phase. After calibration, the proposed NIV can precisely set the airflow with a pressure between 4 cmH₂O and 20 cmH₂O, providing a versatile device that can be used for continuous positive airway pressure (CPAP) or bilevel positive airway pressure (BiPAP). The airflow is generated by a turbine monitored using a mass flow sensor. The whole NIV is monitored with a 16 MHz clock microcontroller. An analog-to-digital converter is used as the input for analog signals, while a digital-to-analog converter is used to drive the turbine. I2C protocol signals are used to manage the display. Moreover, a Wi-Fi system is interfaced for the transmission/reception of clinical and technical information via a smartphone, achieving a remote-controlled NIV.

Background/Objectives: Missing data is a common challenge in neuroscience and neuroimaging studies, especially in the context of neurodegenerative disorders such as Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). Inadequate handling of missing values can compromise the performance and interpretability of machine learning (ML) models. This study aimed to systematically compare the impacts of five imputation methods on classification performance using multimodal data from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Methods: We analyzed a dataset including clinical, cognitive, and neuroimaging features from ADNI participants diagnosed with MCI or AD. Five imputation techniques—mean, median, k-Nearest Neighbors (kNNs), Multiple Imputation by Chained Equations (MICE), and missForest (MF)—were applied. Classification tasks were performed using Random Forest (RF), Logistic Regression (LR), and Support Vector Machine (SVM). Models were trained on the imputed datasets and evaluated on a test set without missing values. The statistical significance of performance differences was assessed using McNemar’s test. Results: On the test set, MICE imputation yielded the highest accuracy for both RF (0.76) and LR (0.81), while SVM performed best with median imputation (0.81). McNemar’s test revealed significant differences between RF and both LR and SVM (p < 0.01), but not between LR and SVM. Simpler methods like mean and median performed adequately but were generally outperformed by MICE. The performance of kNNs and MF was less consistent. Conclusions: Overall, the choice of imputation method significantly affects classification accuracy. Selecting strategies tailored to both data structure and classifier is essential for robust predictive modeling in clinical neuroscience.

The development of even more compact, inexpensive, and highly sensitive gas sensors is widespread, even though their performances are still limited and technological improvements are in continuous evolution. Zeolite is a class of material which has received particular attention in different applications due to its interesting adsorption/desorption capabilities. The behavior of a zeolite 4A modified capacitor has been investigated for the adsorption of nitrogen (N₂), nitric oxide (NO) and 1,1-Difluoroethane (C₂H₄F₂), which are of interest in the field of chemical, biological, radiological, and nuclear threats. Sample measurements were carried out in different environmental conditions, and the variation of the sensor electric capacitance was investigated. The dielectric properties were influenced by the type and concentration of gas species in the environment. Higher changes in capacitance were shown during the adsorption of dry air (+4.2%) and fluorinated gas (+7.3%), while lower dielectric variations were found upon exposure to N₂ (−0.4%) and NO (−0.5%). The proposed approach pointed-out that a simple fabrication process may provide a convenient and affordable fabrication of reusable capacitive gas sensor.

The clinical differential diagnosis between Parkinson’s disease (PD) and progressive supranuclear palsy (PSP) is often challenging. The description of milder PSP phenotypes strongly resembling PD, such as PSP-Parkinsonism, further increased the diagnostic challenge and the need for reliable neuroimaging biomarkers to enhance the diagnostic certainty. This review aims to summarize the contribution of a relatively simple and widely available imaging technique such as MR planimetry in the differential diagnosis between PD and PSP, focusing on the recent advancements in this field. The development of accurate MR planimetric biomarkers, together with the implementation of automated algorithms, led to robust and objective measures for the differential diagnosis of PSP and PD at the individual level. Evidence from longitudinal studies also suggests a role of MR planimetry in predicting the development of the PSP clinical signs, allowing to identify PSP patients before they meet diagnostic criteria when their clinical phenotype can be indistinguishable from PD. Finally, promising evidence exists on the possible association between MR planimetric measures and the underlying pathology, with important implications for trials with new disease-modifying target therapies.